Forget Westpac Banking Corp: Here are 2 shares rated as buys

AGL Energy Ltd (ASX:AGL) and Australian Pharmaceutical Industries Ltd (ASX:API) were recently upgraded to buy ratings by brokers. Now could be a good time to pick up shares.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It has been a day to forget for shareholders of the big four banks today following the disappointing interim results of Westpac Banking Corp (ASX: WBC). With the banks all nursing declines, the S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) has been dragged down by 0.7% so far.

Whilst the banks go through what could be a very turbulent week, I feel it might be best to look further afield and see what else is out there for investors to snap up.

According to CommSec, there are a couple of shares on the ASX which have recently been upgraded to a buy rating by brokers. Perhaps these could be worth considering as alternatives to the banks today.

AGL Energy Ltd (ASX: AGL)

AGL Energy seems to have found favour amongst brokers as it exits the exploration and production side of its business to focus on supplying wholesale and retail customers with energy supplies. It was recently upgraded by them to a moderate buy rating, which could be an indication of share price gains ahead for the soon to be asset-light AGL Energy.

The company has been busy selling non-strategic assets and recently disposed of its 50% share in the Diamantina Power Station for $151 million to APA Group (ASX: APA). This puts it on target to sell $1 billion of non-core assets by FY 2017.

I believe AGL represents a good long term investment prospect that should produce steady growth and a solid dividend.

Australian Pharmaceutical Industries Ltd (ASX: API)

The owner of the Priceline, Soul Pattinson and Pharmacist Advice brands received a strong buy rating at the end of last week. This shouldn't come as a surprise to its shareholders who saw the company deliver an 18% increase in underlying profit at its recent interim results.

The company's pharmacy distribution business has been holding back the company somewhat recently, but management believes that this will start to pick up in due course and complement the accelerating growth of its core business.

The company has plans to grow its store count from 425 stores to 500 within the next few years. I believe this 18% growth in its store network should allow the company to continue growing its sales for a number of years, making an investment today potentially very profitable in my opinion.

Foolish takeaway

Of course, brokers don't always get their ratings right. But I would have to agree with them this time. I believe both shares have the potential to be good long term investments. Just like these fantastic shares are also. Have a look and see for yourself!

Motley Fool contributor James Mickleboro has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »